Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Glomerulonephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07390123
What this trial is testing

Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN

Who this might be right for
IgA Nephropathy (IgAN)
Haisco Pharmaceutical Group Co., Ltd. 370
Testing effectiveness (Phase 2)Study completedNCT03649152
What this trial is testing

Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan

Who this might be right for
Focal Segmental Glomerulosclerosis
Dimerix Bioscience Pty Ltd 8
Large-scale testing (Phase 3)Study completedNCT03493685
What this trial is testing

Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Focal Segmental Glomerulosclerosis
Travere Therapeutics, Inc. 371
Large-scale testing (Phase 3)Active Not RecruitingNCT05797610
What this trial is testing

Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

Who this might be right for
Primary IgA Nephropathy
Hoffmann-La Roche 459
Testing effectiveness (Phase 2)Ended earlyNCT05847920
What this trial is testing

Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Guangdong Hengrui Pharmaceutical Co., Ltd 53
Large-scale testing (Phase 3)Looking for participantsNCT06858319
What this trial is testing

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

Who this might be right for
Kidney DiseasesKidney Diseases, ChronicUrological Diseases+5 more
Novartis Pharmaceuticals 220
Not applicableNot Yet RecruitingNCT06315504
What this trial is testing

Circulating Factors in Nephrotic Syndrome

Who this might be right for
Nephrotic SyndromeMembranous NephropathyMinimal Change Disease+1 more
Iain Bressendorff 104
Testing effectiveness (Phase 2)Looking for participantsNCT03949855
What this trial is testing

Belimumab With Rituximab for Primary Membranous Nephropathy

Who this might be right for
Membranous NephropathyNephrotic Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 58
Not applicableStudy completedNCT00521508
What this trial is testing

Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy

Who this might be right for
Glomerulonephritis, IGA
Centre Hospitalier Universitaire de Saint Etienne 45
Not applicableUnknownNCT06157125
What this trial is testing

Assessment of the Association Between Metabolic Associated Fatty Liver Disease (MFLD) and Biopsy Proved Cases of GN

Who this might be right for
Assessment of Patients With Biopsy Proven Primary Glomerulonephritis Above 18 Years of Age for MFLD Development
Assiut University 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07553494
What this trial is testing

SLN12140 in Adult Participants With IgA Nephropathy in China

Who this might be right for
IgA Nephropathy (IgAN)
Linno Pharmaceuticals, Inc. 48
Not applicableNot Yet RecruitingNCT07746453
What this trial is testing

Universal STAR-T Cell Injection in Autoimmune Kidney Diseases

Who this might be right for
IgA Nephropathy (IgAN)Primary Membranous Nephropathy
Guangdong Provincial People's Hospital 24
Post-approval studies (Phase 4)UnknownNCT02063100
What this trial is testing

Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis

Who this might be right for
GlomerulonephritisProteinuria
Chinese PLA General Hospital 720
Not applicableStudy completedNCT06589752
What this trial is testing

Replication of the NefIgArd Trial of TRF-budesonide in Primary IgAN

Who this might be right for
Primary IgA Nephropathy
Ruijin Hospital 200
Not applicableStudy completedNCT00154661
What this trial is testing

Evaluation of Clinical Efficacy of Pentoxifylline on Patients With Glomerulonephritis

Who this might be right for
Primary Glomerulonephritis
National Taiwan University Hospital 20
Not applicableLooking for participantsNCT06926244
What this trial is testing

RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)

Who this might be right for
IgA Nephropathy (IgAN)
Assistance Publique - Hôpitaux de Paris 800
Testing effectiveness (Phase 2)Ended earlyNCT04652570
What this trial is testing

Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy

Who this might be right for
Membranous Nephropathy
Tenet Medicines 6
Testing effectiveness (Phase 2)Study completedNCT01738035
What this trial is testing

The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease

Who this might be right for
Primary IgA Nephropathy
Calliditas Therapeutics AB 150
Not applicableUnknownNCT02829164
What this trial is testing

Tonsillectomy and Primitive IgA Nephropathy in Children: Strasbourg Cohort and Assessment Practices in Inter North East Region

Who this might be right for
Tonsillectomy
University Hospital, Strasbourg, France 20
Early research (Phase 1)Study completedNCT00193648
What this trial is testing

Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Focal Glomerulosclerosis
Northwell Health 21
Next Page